Incremental innovation consists of introducing in Brazilian market existing assets in the world or promoting incremental improves, such as new associations, formulations, therapeutic indications, and application of different technologies in existing assets, thus bringing innovative proposals to understand the needs of doctors and patients.

Perspectives for the pharmaceutical industry point out to incremental innovation and nanotechnology as promising areas for the next years. Anticipating this trend, in November 2017, Aché inaugurated, at the Guarulhos plant, the NILE- Nanotechnology Innovation Laboratory Enterprise laboratory, in partnership with the company Ferring Pharmaceuticals. The laboratory has the latest equipment to apply nanotechnology to prototypes that can later be transferred to industrial scale. Currently, the laboratory is already starting its first proof of concept study, in vivo, with this objective and with the expectation of having the first results in the first quarter of 2020.

For the incremental innovation platform called Innovatech®, the main mission is the application of new technologies in known molecules to solve problems related to stability, solubility, bioavailability, flavor, low action time and route of administration, allowing the development of pharmaceutical products respond to unmet medical needs.